EPO and myelodysplastic syndrome: EPO treatment of mesenchymal stem cells from MDS patients inhibited Wnt signaling and reactivation of Wnt signaling combined with EPO treatment promoted their differentiation to osteoblasts (Balaian et al., 2018).